174 related articles for article (PubMed ID: 15149778)
1. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture.
Genzel Y; Behrendt I; König S; Sann H; Reichl U
Vaccine; 2004 Jun; 22(17-18):2202-8. PubMed ID: 15149778
[TBL] [Abstract][Full Text] [Related]
2. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
3. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
Genzel Y; Olmer RM; Schäfer B; Reichl U
Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
[TBL] [Abstract][Full Text] [Related]
4. Mathematical model of influenza A virus production in large-scale microcarrier culture.
Möhler L; Flockerzi D; Sann H; Reichl U
Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
[TBL] [Abstract][Full Text] [Related]
5. Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells.
Genzel Y; Ritter JB; König S; Alt R; Reichl U
Biotechnol Prog; 2005; 21(1):58-69. PubMed ID: 15903241
[TBL] [Abstract][Full Text] [Related]
6. Serum-free suspension cultivation of PER.C6(R) cells and recombinant adenovirus production under different pH conditions.
Xie L; Pilbrough W; Metallo C; Zhong T; Pikus L; Leung J; Auniņs JG; Zhou W
Biotechnol Bioeng; 2002 Dec; 80(5):569-79. PubMed ID: 12355468
[TBL] [Abstract][Full Text] [Related]
7. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
[TBL] [Abstract][Full Text] [Related]
8. Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.
Isken B; Genzel Y; Reichl U
Vaccine; 2012 Jul; 30(35):5253-61. PubMed ID: 22698452
[TBL] [Abstract][Full Text] [Related]
9. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
10. Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine.
Brands R; Visser J; Medema J; Palache AM; van Scharrenburg GJ
Dev Biol Stand; 1999; 98():93-100; discussion 111. PubMed ID: 10494962
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
12. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
[TBL] [Abstract][Full Text] [Related]
13. Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector.
Maranga L; Auniņs JG; Zhou W
Biotechnol Bioeng; 2005 Jun; 90(5):645-55. PubMed ID: 15834950
[TBL] [Abstract][Full Text] [Related]
14. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines.
Kalbfuss B; Genzel Y; Wolff M; Zimmermann A; Morenweiser R; Reichl U
Biotechnol Bioeng; 2007 May; 97(1):73-85. PubMed ID: 16921531
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
16. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
17. Downstream processing of MDCK cell-derived equine influenza virus.
Nayak DP; Lehmann S; Reichl U
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):75-81. PubMed ID: 16009601
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels.
Maranga L; Goochee CF
Biotechnol Bioeng; 2006 May; 94(1):139-50. PubMed ID: 16523524
[TBL] [Abstract][Full Text] [Related]
19. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
Peschel B; Frentzel S; Laske T; Genzel Y; Reichl U
Vaccine; 2013 Nov; 31(48):5693-9. PubMed ID: 24113260
[TBL] [Abstract][Full Text] [Related]
20. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
Seifert DB; Phillips JA
Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
